Sudarshan Pharma acquires 100% stake in Cibachem General Trading
Sudarshan Pharma's board approved full acquisition of Cibachem General Trading for ₹55 lakh. This aims to broaden their Middle East customer reach. The acquisition of 100% equity (300 shares) is subject to RBI approval, with a target completion date of September 30, 2025.